CHERYL HICKEY: Open Payments
NPI 1386798577 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 17 payments from 9 companies in 2025. Trend: 2023 $2,068 · 2024 $624 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $157 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| United Therapeutics Corporation | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| CVRx, Inc. | 1 | $9 |
Products named: CAMZYOS, JARDIANCE, WINREVAIR, OPSUMIT, ELIQUIS, Orenitram, VERQUVO, UPTRAVI.
Industry payments across OH — which companies pay providers there.
